FDA Approvals in Oncology: October-December 2024
In the final three months of 2024, the FDA issued 15 approvals in oncology, including several therapies that are...
Tag: Lung cancer
In the final three months of 2024, the FDA issued 15 approvals in oncology, including several therapies that are...
Recent advances in EGFR inhibition include combinations to overcome resistance and approvals for newly diagnosed or early-stage lung cancers.
This quarter’s 16 approvals include a first-in-class cell therapeutic, a flurry of new options for EGFR-mutated lung cancer, and...
Researchers at the AACR Annual Meeting 2024 shared how AACR Project GENIE data is helping their studies.
Roughly 6 percent of men and women in the United States will be diagnosed with lung and bronchus cancer...
Over the course of the two-day AACR Virtual Annual Meeting I, more than 61,000 people from 140 countries around the...
Screening for lung cancer using low-dose computed tomography (CT) was introduced in the United States in 2013. Recent data...
Lung cancer – one of the most commonly diagnosed cancers in the United States – is an area of...
During late March and early April, the U.S. Food and Drug Administration (FDA) made several decisions that have increased...
About 80 percent of lung cancers are non-small cell lung cancers (NSCLC), and about 15 to 20 percent of...